Ajanta Pharma posts Q2 FY24 consolidated PAT at Rs. 195.30 Cr
News

Ajanta Pharma posts Q2 FY24 consolidated PAT at Rs. 195.30 Cr

Ajanta Pharma has reported total income of Rs. 1049.77 crores during the period ended September 30, 2023

  • By IPP Bureau | November 01, 2023

Ajanta Pharma Limited has reported Consolidated financial results for the period ended September 30, 2023.

Ajanta Pharma has posted net profit of Rs. 195.30 crores for the period ended September 30, 2023 as against net profit of Rs. 208.12 crores for the period ended June 30, 2023. The company posted net profit of Rs.156.60 crores for the period ended September 30, 2022.

Ajanta Pharma has reported total income of Rs. 1049.77 crores during the period ended September 30, 2023 as compared to Rs. 1052.79 crores during the period ended June 30, 2023. The company reported total income of Rs.978.45 crores during the period ended September 30, 2022.

For the Hlaf Year ended September 30, 2023, Ajanta Pharma has reported total income of Rs.2092.57 crores as compared to Rs.1962.14 crores during the 6 months period ended September 30, 2022.

The company has posted net profit of Rs.403.42 crores for the 6 months period ended September 30, 2023 as against net profit of Rs.331.22 crores for the 6 months period ended September 30, 2022.

Upcoming E-conference

Other Related stories

Startup

Digitization